1. Home
  2. SLNO
  3. SLNO News

Latest Soleno Therapeutics Inc. (SLNO) News on January 22, 2025

Is Soleno Therapeutics (SLNO) the Top Small Cap Stock to Buy with the Highest Upside Potential?
SLNO

Insider Monkey

9 days ago

Is Soleno Therapeutics (SLNO) the Top Small Cap Stock to Buy with the Highest Upside Potential?

Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven?
SLNO

Simply Wall St.

15 days ago

Soleno Therapeutics, Inc. (NASDAQ:SLNO): When Will It Breakeven?

SLNO

MT Newswires

a month ago

Soleno Therapeutics Gets $200 Million Debt Financing From Oxford Finance

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC
SLNO

GlobeNewswire

a month ago

Soleno Therapeutics Enters Into $200 Million Debt Financing with Oxford Finance LLC

High Growth Tech Stocks to Watch in November 2024
SLNO

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in November 2024

Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
SLNO

GlobeNewswire

2 months ago

Soleno Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference

FDA delays decision of Soleno’s Prader-Willi syndrome drug
SLNO

Pharmaceutical Technology

2 months ago

FDA delays decision of Soleno’s Prader-Willi syndrome drug

Kronos, Idorsia plan layoffs; PTC shelves ALS drug
SLNO

BioPharma Dive

2 months ago

Kronos, Idorsia plan layoffs; PTC shelves ALS drug

Soleno Tumbles 17% as FDA Extends Review Timeline for Prader-Willi Treatment
SLNO

GuruFocus.com

2 months ago

Soleno Tumbles 17% as FDA Extends Review Timeline for Prader-Willi Treatment

SLNO

MT Newswires

2 months ago

Soleno Therapeutics Says FDA Extends DCCR NDA Review Citing 'Major Amendment'

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
SLNO

GlobeNewswire

2 months ago

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024
SLNO

GlobeNewswire

2 months ago

Soleno Therapeutics Announces Oral Presentations featuring Diazoxide Choline Extended-Release (DCCR) Tablets in Prader-Willi Syndrome at ESPE 2024

Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation
SLNO

Simply Wall St.

2 months ago

Here's Why We're Not At All Concerned With Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn Situation

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
SLNO

GlobeNewswire

3 months ago

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Soleno Therapeutics to Participate in Upcoming November Investor Conferences
SLNO

GlobeNewswire

3 months ago

Soleno Therapeutics to Participate in Upcoming November Investor Conferences

Lamb Weston, Adecoagro, and More Stocks See Action From Activist Investors
SLNO

Barrons.com

3 months ago

Lamb Weston, Adecoagro, and More Stocks See Action From Activist Investors

Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.
SLNO

GlobeNewswire

3 months ago

Soleno Therapeutics Announces the Passing of Former Chairman Ernest Mario, Ph.D.

TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors
SLNO

Barrons.com

3 months ago

TriMas, Soleno Therapeutics, Ring Energy, and More Stocks See Action From Activist Investors

Soleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCR
SLNO

Insider Monkey

3 months ago

Soleno Therapeutics (SLNO): Pioneering Treatment for Prader-Willi Syndrome with DCCR

Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment
SLNO

Insider Monkey

3 months ago

Soleno Therapeutics (SLNO): Breakthroughs in Prader-Willi Syndrome Treatment

Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.
SLNO

GuruFocus.com

3 months ago

Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA
SLNO

Zacks

3 months ago

SLNO Stock Rises on Upbeat Regulatory Update on PWS Drug NDA

Why Soleno Therapeutics Stock Blasted 9% Higher Today
SLNO

Motley Fool

3 months ago

Why Soleno Therapeutics Stock Blasted 9% Higher Today

SLNO

MT Newswires

3 months ago

Soleno Therapeutics Says US FDA Determines NDA for DCCR Does Not Need Advisory Panel Meeting for Now

Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
SLNO

GlobeNewswire

3 months ago

Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome

SLNO

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 10/04/2024

SLNO

MT Newswires

4 months ago

Soleno Therapeutics Insider Sold Shares Worth $1,069,306, According to a Recent SEC Filing

Janus Henderson Group PLC's Strategic Acquisition in Soleno Therapeutics Inc
SLNO

GuruFocus.com

4 months ago

Janus Henderson Group PLC's Strategic Acquisition in Soleno Therapeutics Inc

High Growth Tech Stocks To Watch In The United States
SLNO

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In The United States

Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference
SLNO

GlobeNewswire

4 months ago

Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference

Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.
SLNO

GuruFocus.com

4 months ago

Carlyle Group Inc.'s Strategic Reduction in Soleno Therapeutics Inc.

SLNO

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 09/03/2024

SLNO

MT Newswires

5 months ago

HC Wainwright Initiates Soleno Therapeutics at Buy

High Growth Tech Stocks To Watch In September 2024
SLNO

Simply Wall St.

5 months ago

High Growth Tech Stocks To Watch In September 2024

SLNO

MT Newswires

5 months ago

Soleno Therapeutics Insider Sold Shares Worth $5,454,707, According to a Recent SEC Filing

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review
SLNO

Zacks

5 months ago

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review

Soleno wins FDA priority review for Prader-Willi therapy
SLNO

Pharmaceutical Technology

5 months ago

Soleno wins FDA priority review for Prader-Willi therapy

Soleno Therapeutics, Inc. (SLNO): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
SLNO

Insider Monkey

5 months ago

Soleno Therapeutics, Inc. (SLNO): One of Oppenheimer’s Top Stock Picks For the Next 12 Months

SLNO

MT Newswires

5 months ago

Soleno Therapeutics Says FDA Accepts Application for Prader-Willi Syndrome Drug

Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome
SLNO

GlobeNewswire

5 months ago

Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SLNO

GlobeNewswire

5 months ago

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLNO

MT Newswires

5 months ago

Soleno Therapeutics Chairman Ernest Mario Stepping Down

Soleno Therapeutics Announces Updates to its Board of Directors
SLNO

GlobeNewswire

5 months ago

Soleno Therapeutics Announces Updates to its Board of Directors

SLNO

MT Newswires

5 months ago

Oppenheimer Adjusts Soleno Therapeutics' PT to $65 From $59, Maintains Outperform Rating

SLNO

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 08/08/2024

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
SLNO

GlobeNewswire

5 months ago

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

When Can We Expect A Profit From Soleno Therapeutics, Inc. (NASDAQ:SLNO)?
SLNO

Simply Wall St.

6 months ago

When Can We Expect A Profit From Soleno Therapeutics, Inc. (NASDAQ:SLNO)?

These Stock Winners Are ‘Strong Buys’ With More Room Left to Run
SLNO

TipRanks

6 months ago

These Stock Winners Are ‘Strong Buys’ With More Room Left to Run

SLNO

MT Newswires

7 months ago

Soleno Therapeutics Submits New Drug Application to FDA for Prader-Willi Syndrome Treatment

Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
SLNO

GlobeNewswire

7 months ago

Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SLNO

GlobeNewswire

7 months ago

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SLNO

MT Newswires

8 months ago

Soleno Therapeutics to Join Russell 3000 Index

Soleno Therapeutics Set to Join Russell 3000® Index
SLNO

GlobeNewswire

8 months ago

Soleno Therapeutics Set to Join Russell 3000® Index

Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
SLNO

GlobeNewswire

8 months ago

Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024

Soleno Therapeutics to Participate in Upcoming Investor Conferences
SLNO

GlobeNewswire

8 months ago

Soleno Therapeutics to Participate in Upcoming Investor Conferences

Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
SLNO

GlobeNewswire

8 months ago

Soleno Therapeutics Stands with the Prader-Willi Syndrome Community

SLNO

MT Newswires

8 months ago

Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
SLNO

GlobeNewswire

8 months ago

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most
SLNO

Simply Wall St.

8 months ago

While institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the most

SLNO

MT Newswires

9 months ago

Soleno Therapeutics Prices $138 Million Stock Offering

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
SLNO

GlobeNewswire

9 months ago

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock

Soleno Therapeutics Announces Proposed Public Offering of Common Stock
SLNO

GlobeNewswire

9 months ago

Soleno Therapeutics Announces Proposed Public Offering of Common Stock

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
SLNO

GlobeNewswire

9 months ago

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome

SLNO

MT Newswires

9 months ago

Soleno Therapeutics' Shares Jump After FDA Grants Breakthrough Designation for Prader-Willi Syndrome Treatment

Why Soleno Therapeutics Stock Is Skyrocketing Today
SLNO

Motley Fool

9 months ago

Why Soleno Therapeutics Stock Is Skyrocketing Today

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
SLNO

GlobeNewswire

9 months ago

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SLNO

GlobeNewswire

9 months ago

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
SLNO

GuruFocus.com

10 months ago

CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)

Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
SLNO

GuruFocus.com

10 months ago

Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)

We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn
SLNO

Simply Wall St.

10 months ago

We're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash Burn

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SLNO

GlobeNewswire

10 months ago

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
SLNO

GlobeNewswire

a year ago

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
SLNO

GlobeNewswire

a year ago

Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why
SLNO

Zacks

a year ago

Soleno Therapeutics, Inc. (SLNO) Is a Great Choice for 'Trend' Investors, Here's Why

Charter downgraded, Cigna upgraded: Wall Street's top analyst calls
SLNO

The Fly

a year ago

Charter downgraded, Cigna upgraded: Wall Street's top analyst calls

Soleno Therapeutics to Present at Upcoming February Investor Conferences
SLNO

GlobeNewswire

a year ago

Soleno Therapeutics to Present at Upcoming February Investor Conferences

SLNO

Associated Press Finance

a year ago

Boot Barn: Fiscal Q3 Earnings Snapshot

Boot Barn (NYSE:BOOT) Misses Q3 Sales Targets
SLNO

StockStory

a year ago

Boot Barn (NYSE:BOOT) Misses Q3 Sales Targets

SLNO

Business Wire

a year ago

Boot Barn Holdings, Inc. Announces Third Quarter Fiscal Year 2024 Financial Results

Hess Midstream LP Announces Guidance, Increases and Extends Return of Capital Program Through 2026
SLNO

Business Wire

a year ago

Hess Midstream LP Announces Guidance, Increases and Extends Return of Capital Program Through 2026

Analysts Expect Breakeven For Soleno Therapeutics, Inc. (NASDAQ:SLNO) Before Long
SLNO

Simply Wall St.

a year ago

Analysts Expect Breakeven For Soleno Therapeutics, Inc. (NASDAQ:SLNO) Before Long

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SLNO

GlobeNewswire

a year ago

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Hexcel (NYSE:HXL) Has Announced That It Will Be Increasing Its Dividend To $0.15
SLNO

Simply Wall St.

a year ago

Hexcel (NYSE:HXL) Has Announced That It Will Be Increasing Its Dividend To $0.15

Kraft Heinz's (KHC) Pricing & Transformation Efforts Solid
SLNO

Zacks

a year ago

Kraft Heinz's (KHC) Pricing & Transformation Efforts Solid

PJT Partners Inc. to Report Full Year and Fourth Quarter 2023 Financial Results and Host a Conference Call on February 6, 2024
SLNO

Business Wire

a year ago

PJT Partners Inc. to Report Full Year and Fourth Quarter 2023 Financial Results and Host a Conference Call on February 6, 2024

Delek US Holdings to Host Fourth Quarter 2023 Conference Call on February 27th
SLNO

PR Newswire

a year ago

Delek US Holdings to Host Fourth Quarter 2023 Conference Call on February 27th

Company News for Jan 26, 2024
SLNO

Zacks

a year ago

Company News for Jan 26, 2024

Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going
SLNO

Zacks

a year ago

Here's Why Momentum in Soleno Therapeutics, Inc. (SLNO) Should Keep going

JinkoSolar's Subsidiary Jinko Solar Co., Ltd. Announces Estimates of Certain Preliminary Unaudited Financial Results for Full Year 2023
SLNO

PR Newswire

a year ago

JinkoSolar's Subsidiary Jinko Solar Co., Ltd. Announces Estimates of Certain Preliminary Unaudited Financial Results for Full Year 2023

Soleno Therapeutics Strengthens Leadership Team with Key Appointments
SLNO

GlobeNewswire

a year ago

Soleno Therapeutics Strengthens Leadership Team with Key Appointments

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade
SLNO

Zacks

a year ago

Wall Street Analysts Believe Harmony Biosciences Holdings, Inc. (HRMY) Could Rally 28.77%: Here's is How to Trade

SAPIENS TO ANNOUNCE FOURTH QUARTER and YEAR-END 2023 FINANCIAL RESULTS ON FEBRUARY 20, 2024
SLNO

PR Newswire

a year ago

SAPIENS TO ANNOUNCE FOURTH QUARTER and YEAR-END 2023 FINANCIAL RESULTS ON FEBRUARY 20, 2024

SLNO

Associated Press Finance

a year ago

Forestar Group: Fiscal Q1 Earnings Snapshot

Forestar Reports Fiscal 2024 First Quarter Results
SLNO

Business Wire

a year ago

Forestar Reports Fiscal 2024 First Quarter Results

What Caused the Collapse in Natural Gas Prices Last Week?
SLNO

Zacks

a year ago

What Caused the Collapse in Natural Gas Prices Last Week?

ENVESTNET DELIVERING INDUSTRY-LEADING CONNECTIVITY AND ADVANCES TO ITS WEALTH MANAGEMENT PLATFORM
SLNO

PR Newswire

a year ago

ENVESTNET DELIVERING INDUSTRY-LEADING CONNECTIVITY AND ADVANCES TO ITS WEALTH MANAGEMENT PLATFORM

SLNO

The Wall Street Journal

a year ago

Blackstone Is Moving Back Into Rental Homes With Tricon Deal

SLNO

Associated Press Finance

a year ago

Banner: Q4 Earnings Snapshot

Banner Corporation Reports Net Income of $42.6 Million, or $1.24 Per Diluted Share, for 4th Quarter 2023; Earns $183.6 Million in Net Income, or $5.33 Per Diluted Share, for the Full Year of 2023; Declares Quarterly Cash Dividend of $0.48 Per Share
SLNO

Business Wire

a year ago

Banner Corporation Reports Net Income of $42.6 Million, or $1.24 Per Diluted Share, for 4th Quarter 2023; Earns $183.6 Million in Net Income, or $5.33 Per Diluted Share, for the Full Year of 2023; Declares Quarterly Cash Dividend of $0.48 Per Share

Analysts Expect Breakeven For Elanco Animal Health Incorporated (NYSE:ELAN) Before Long
SLNO

Simply Wall St.

a year ago

Analysts Expect Breakeven For Elanco Animal Health Incorporated (NYSE:ELAN) Before Long

Share on Social Networks: